(Q37709556)

22 August 2017

1 reference

title

Anti-inflammatory agents as cancer therapeutics (English)

1 reference

22 August 2017

0 references

Khosrow Kashfi

1

1 reference

22 August 2017

27 November 2009

1 reference

22 August 2017

Advances in Pharmacology

1 reference

22 August 2017

57

1 reference

22 August 2017

31-89

1 reference

The possible role of hydrogen sulfide as an endogenous neuromodulator.

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of human glutathione S-transferases by curcumin and analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The tumor microenvironment: key to early detection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The thioredoxin system in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Functional characteristics of cysteinyl-leukotriene receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene signaling in atherosclerosis and ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene receptors in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

In vivo activation of an omega-6 oxygenase in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Tumour necrosis factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Multi-targeted therapy of cancer by genistein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A critical review of the literature on hydrogen sulfide toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Interaction between CXCR4 and CCL20 pathways regulates tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Role of hydrogen sulfide in acute pancreatitis and associated lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Targeting signal transduction pathways by chemopreventive agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Novel neural modulators

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Discovery of a second 15S-lipoxygenase in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostanoid receptors: subtypes and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nutritional supplements for older adults: review and recommendations-part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Expression of human cystathionine beta-synthase in Escherichia coli: purification and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric-oxide releasing molecules: a new class of drugs with several major indications

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostaglandin E2 increases cyp19 expression in rat granulosa cells: implication of GATA-4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Molecular and functional aspects of human cysteinyl leukotriene receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

In vitro metabolism of a nitroderivative of acetylsalicylic acid (NCX4016) by rat liver: LC and LC-MS studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Does diet or alcohol explain the French paradox?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A novel anti-pancreatic cancer agent, LY293111.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-releasing NSAIDs are caspase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-aspirin protects from T cell–mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Mechanisms of nitrate tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene modifiers as potential therapeutics for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin induces phase II enzymes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inflammatory resolution: new opportunities for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Sulfide, the first inorganic substrate for human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Structure, function, and regulation of leukotriene A4 hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Colon cancer: preventive agents and the present status of chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

New lessons: classic treatments, expanding options in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Effect of LY293111 in combination with gemcitabine in colonic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

1 reference

7 January 2021

Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

1 reference

7 January 2021

The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Impaired nitrate-mediated dilatation could reflect nitrate tolerance in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of tumour growth by lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The mechanism of action of nitric oxide-donating aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

From O2 to H2S: a landscape view of gas biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Pranlukast: a review of its use in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Lipoxygenase inhibitors for the treatment of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Involvement of tyrosine kinases and MAP kinases in the production of TNF-alpha and IL-1beta by macrophages in vitro on treatment with phytohemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inflammation: gearing the journey to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nrf2 as a novel molecular target for chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

New trends in dual 5-LOX/COX inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulphide--a novel mediator of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Ginsenosides in Roots and Leaves of American Ginseng†

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Preclinical mouse models for cancer chemoprevention studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokines: immunology's high impact factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Sulfide enhancement of PMN apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Origin and physiological roles of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Structure of human cystathionine beta-synthase: a unique pyridoxal 5'-phosphate-dependent heme protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Systemic therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Identification and isolation of a membrane protein necessary for leukotriene production

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

WNT and beta-catenin signalling: diseases and therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Friends or foes - bipolar effects of the tumour stroma in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokines and the molecular basis of cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibition of mouse epidermal 12-lipoxygenase by 2,3,4-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinon e (AA861)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The role of nitric oxide in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

An overview of acetic acid ulcer models--the history and state of the art of peptic ulcer research

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NF-kappa B signaling and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A molecular view of microbial diversity and the biosphere

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemopreventive effects of natural dietary compounds on cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Modulation of inflammatory genes by natural dietary bioactive compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Regulation of cyclooxygenase-2 expression by nitric oxide in cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Vitamin D and the skin: an ancient friend, revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Toxicology of Hydrogen Sulfide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The biphasic nature of nitric oxide responses in tumor biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A large blood pressure-raising effect of nitric oxide synthase inhibition in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chronic inflammation: a common and important factor in the pathogenesis of neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Sulfur reduction by human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The chemokine network: a target in cancer biology?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A comparison of the anticarcinogenic properties of four red wine polyphenols

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

CXC chemokines in angiogenesis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Structure-function aspects in the nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokines in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitrates and NO release: contemporary aspects in biological and medicinal chemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide synthase activity in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

1 reference

7 January 2021

IL-1 is required for tumor invasiveness and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Building a better aspirin: gaseous solutions to a century-old problem

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide-releasing anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Gastrointestinal Safety and Anti-Inflammatory Effects of a Hydrogen Sulfide–Releasing Diclofenac Derivative in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The therapeutic potential of NO-NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide enhances ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Potential cardioprotective actions of no-releasing aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Nitric oxide in mucosal defense: a little goes a long way.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A diclofenac derivative without ulcerogenic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in Syrian hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Biological sulfane sulfur

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The multifaceted roles of nitric oxide in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokine receptors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The role of nitric oxide in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene B4: metabolism and signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

Chemokines and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957002-5

7 January 2021

10.1016/S1054-3589(08)57002-5

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20230759